New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti-Inflammatory and Anticancer Activity Studies.
Chem Biodivers
; 20(8): e202300773, 2023 Aug.
Article
em En
| MEDLINE
| ID: mdl-37384873
ABSTRACT
In this study, twenty new anthranilic acid hydrazones 6-9 (a-e) were synthesized and their structures were characterized by Fourier-transform Infrared (FT-IR), Nuclear Magnetic Resonance (1 H-NMR - 13 C-NMR), and High-resolution Mass Spectroscopy (HR-MS). The inhibitory effects of the compounds against COX-II were evaluated. IC50 values of the compounds were found in the range of >200-0.32â
µM and compounds 6e, 8d, 8e, 9b, 9c, and 9e were determined to be the most effective inhibitors. Cytotoxic effects of the most potent compounds were investigated against human hepatoblastoma (Hep-G2) and human healthy embryonic kidney (Hek-293) cell lines. Doxorubicin (IC50 8.68±0.16â
µM for Hep-G2, 55.29±0.56â
µM for Hek-293) was used as standard. 8e is the most active compound, with low IC50 against Hep-G2 (4.80±0.04â
µM), high against Hek-293 (159.30±3.12), and high selectivity (33.15). Finally, molecular docking and dynamics studies were performed to understand ligand-protein interactions between the most potent compounds and COXâ
II, Epidermal Growth Factor Receptor (EGFR), and Transforming Growth Factor betaâ
II (TGF-ßII). The docking scores were calculated in the range of -10.609--6.705â
kcal/mol for COX-II, -8.652--7.743â
kcal/mol for EGFR, and -10.708--8.596â
kcal/mol for TGF-ßII.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fenamatos
/
Antineoplásicos
Limite:
Humans
Idioma:
En
Revista:
Chem Biodivers
Assunto da revista:
BIOQUIMICA
/
QUIMICA
Ano de publicação:
2023
Tipo de documento:
Article